GraniteShares 2x Long COIN Daily ETF vs Zoetis Inc — how do they compare? GraniteShares 2x Long COIN Daily ETF trades at $5.26 (market cap $510.01M), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 59.2× GraniteShares 2x Long COIN Daily ETF's market cap, and Zoetis Inc pays a 2.9% dividend while GraniteShares 2x Long COIN Daily ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold GraniteShares 2x Long COIN Daily ETF for 15 Days and Zoetis Inc for 70 Days on average.
| CONL | ZTS | |
|---|---|---|
Market Cap | $510.01M | $30.20B |
Volume | 21,041,836 | 6,175,327 |
Sector | Leveraged / Inverse | Health |
52-Week High | $48.58 | $147.53 |
52-Week Low | $3.93 | $69.09 |
Typical Hold Time | 15 Days | 70 Days |
Enterprise Value | — | $37.76B |
Dividend Yield | — | 2.9% |
Signals from Pluang's Aura AI — not financial advice
CONL, the GraniteShares 2x Long COIN Daily ETF, trades at $4.85, down 7.27% with bearish technical signals from moving averages. The ETF provides leveraged exposure to Coinbase stock, experiencing significant volatility as highlighted in recent financial media coverage. Key oscillators show oversold conditions with RSI readings below 22, suggesting potential for near-term bounce.
The outlook remains challenging given the leveraged structure's sensitivity to Coinbase volatility. Investment opportunity exists for tactical traders betting on Coinbase recovery, but risks include amplified losses during downtrends and the structural decay inherent in daily reset leveraged products.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
CONL is a leveraged ETF that seeks to provide two times (2x) the daily performance of Coinbase Global (COIN) stock. It is designed for investors seeking magnified short-term exposure to the price movements of Coinbase.
Read more on CONL →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →